The study uncovered a mechanism involving miR-200b-3p, ZEB1, E2F3, and the IGF1R/PI3K/AKT axis, suggesting a potential therapeutic approach for CRC (Gong et al., 2023). The gene discussed is AKT1; the disease is colorectal carcinoma.